✦ LIBER ✦

Discovery of BMS-846372, a Potent and Orally Active Human CGRP Receptor Antagonist for the Treatment of Migraine

✍ Scribed by Luo, Guanglin; Chen, Ling; Conway, Charles M.; Denton, Rex; Keavy, Deborah; Gulianello, Michael; Huang, Yanling; Kostich, Walter; Lentz, Kimberley A.; Mercer, Stephen E.

Book ID: 111891463
Publisher: American Chemical Society
Year: 2012
Tongue: English
Weight: 554 KB
Volume: 3
Category: Article
ISSN: 1948-5875
DOI: 10.1021/ml300021s

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The discovery of L-699,392, a novel pote

The discovery of L-699,392, a novel potent and orally active leukotriene D4 receptor antagonist

✍ M. Labelle; M. Belley; E. Champion; R. Gordon; K. Hoogsteen; T.R. Jones; Y. Lebl 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 311 KB

Discovery of Novel, Potent, and Orally A

Discovery of Novel, Potent, and Orally Active Spiro-Urea Human Glucagon Receptor Antagonists.

✍ Dong-Ming Shen; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 28 KB 👁 2 views

Discovery of a Potent, Selective, and Or

Discovery of a Potent, Selective, and Orally Active Human Epidermal Growth Factor Receptor-2 Sheddase Inhibitor for the Treatment of Cancer†

✍ Yao, Wenqing; Zhuo, Jincong; Burns, David M.; Xu, Meizhong; Zhang, Colin; Li, Yu 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 79 KB

Clinical and Preclinical Rationale for C

Clinical and Preclinical Rationale for CGRP-Receptor Antagonists in the Treatment of Migraine

✍ Stewart J. Tepper; Mark J. Stillman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

Discovery of novel, potent, selective, a

Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core

✍ Dong-Ming Shen; Edward J. Brady; Mari R. Candelore; Qing Dallas-Yang; Victor D.- 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 461 KB

A novel class of 1,3,5-pyrazoles has been discovered as potent human glucagon receptor antagonists. Notably, compound 26 is orally bioavailable in several preclinical species and shows selectivity towards cardiac ion channels, other family B receptors such hGIP and hGLP1, and a large panel of enzyme

Discovery of a Potent, Selective, and Or

Discovery of a Potent, Selective, and Orally Active Proteasome Inhibitor for the Treatment of Cancer

✍ Dorsey, Bruce D.; Iqbal, Mohamed; Chatterjee, Sankar; Menta, Ernesto; Bernardini 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 161 KB